Angela Pine

Angela Pine is a Lecturer at the School of Life Sciences, University of Essex, specializing in HPV infection dynamics, functional nucleic acids, and biomedical innovation. She combines computational modeling and experimental approaches to develop gene therapies and diagnostic tools.

• HCPC registered Biomedical Scientist
• Founder of 10zyme (HPV diagnostic accessibility)
• Member of HPV Coalition (UK policy roadmap)

Research Focus: Persistent HPV infections, DNAzyme efficiency, vaginal microbiome interactions, and mental health impacts of HPV diagnoses. Her work bridges molecular biology with public health, targeting global cancer prevention disparities.

• Key projects: Diagnostic assays, RNA-cleaving DNAzymes, microbiome analysis, HPV vaccination literacy
• Patents: Novel gene therapy and nanoparticle delivery system

Scientific Awards:

• Fellow of the Institute of Biomedical Science
• 2 patents (2023) for prostate cancer therapies

Teaching: Leads courses in molecular virology, cell biology, and biomedical science employability. Supervises research projects in HPV diagnostics and nucleic acid therapies.